Skip to content
TriVascular, Inc logo — company profile

TriVascular, Inc

Founded 1998 United States Santa Rosa, United States 42 employees Post-IPO Debt Total: $412.95M Health Care, Medical Devices

General Information

Company Name TriVascular, Inc
Founded Year 1998
Location United States Santa Rosa, United States
Founders / Decision Makers
Team member Team member Team member
Employees 42
Industries Health Care, Medical Devices
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with TriVascular, Inc. To contact TriVascular, Inc, visit trivascular.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does TriVascular, Inc compare?

A PDF of TriVascular, Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting TriVascular, Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About TriVascular, Inc

TriVascular, Inc. is a pioneering company in the health care industry, committed to creating optimal solutions for endovascular aortic repair (EVAR). Since its establishment in 1998 in the United States, TriVascular has been at the forefront of developing innovative design and manufacturing technologies. The company's primary focus is on novel endovascular grafts aimed at advancing EVAR, addressing unmet clinical needs, and broadening the pool of EVAR-eligible patients. TriVascular's approach involves collaborating with esteemed clinicians globally to ensure that its products not only meet but exceed the demands of the market. In August 21, 2015, the company secured a significant $10.00M Post-IPO Debt investment. This investment serves as a testament to the confidence that investors have in TriVascular's potential to shape the future of endovascular aortic repair. With its continuous dedication to innovation and expansion, TriVascular is poised to make a lasting impact in the health care industry, addressing critical challenges in aortic repair procedures.

Business keywords: Endovascular Aortic Repair, EVAR, Aortic Aneurysm Treatment, Stent-Grafts, Medical Technology, Healthcare Innovation, Vascular Surgery, Startup, Biomedical Engineering, Clinical Partnerships, Innovative Design, Manufacturing Technologies, Employee Benefits, Quality of Life

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $10.00M -
21 Aug 2015
Venture Round $1.95M -
12 Dec 2013
Series E $40.00M 9
New Enterprise Associates, Kaiser Permanente Ventures +7
18 Nov 2013
Debt Financing $96.00M 2
Greenspring Associates, CRG
01 Feb 2013
Series D $60.00M 7
New Enterprise Associates, Kaiser Permanente Ventures +5
04 Jun 2012
Debt Financing $50.00M -
01 Jan 2012
Series C $60.00M 5
New Enterprise Associates, MPM Capital +3
12 Aug 2010
Series B $30.00M 4
New Enterprise Associates, MPM Capital +2
16 Nov 2009
Series A $65.00M 4
New Enterprise Associates, MPM Capital +2
31 Mar 2008

TriVascular, Inc Alternatives & Competitors

View All Alternatives
TriVascular, Inc vs

Discover why endovascular clinicians around the world are excited about the VESTECK, "SUTURE-TIGHT"...

Convertible Note
8 employees
Health Care, Manufacturing
TriVascular, Inc vs
Vascutek
Vascutek United Kingdom

Vascutek is now Terumo Aortic. Please follow @TerumoAortic for latest updates.

Venture round
139 employees
Health Care, Manufacturing
TriVascular, Inc vs

Precision Tools for Rapid and Safe Vascular Occlusion Procedures

Series A
11-50 employees
Biotechnology, Health Care

FAQ About TriVascular, Inc

TriVascular has pioneered numerous design and manufacturing technologies in pursuit of our commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular’s initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon par...
TriVascular, Inc was founded in 1998.
TriVascular, Inc is headquartered in Santa Rosa, United States.
TriVascular, Inc operates in Health Care and Medical Devices. Its work centres on Endovascular Aortic Repair, EVAR, Aortic Aneurysm Treatment and Stent-Grafts.
TriVascular, Inc has approximately 42 employees.
TriVascular, Inc has completed 9 funding rounds, raising a total of $412.95M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to TriVascular, Inc include VESTECK, Inc, Vascutek, Artio Medical, Taurus Vascular, Fluid Biomed Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TriVascular, Inc and VESTECK, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for TriVascular, Inc, https://bouncewatch.com/company/trivascular-inc, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout